• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

南非献血者中的细小病毒 B19。

Parvovirus B19 in South African blood donors.

机构信息

Department of Virology, National Health Laboratory Service and University of KwaZulu-Natal, Durban, KwaZulu-Natal, South Africa.

出版信息

J Med Virol. 2019 Jul;91(7):1217-1223. doi: 10.1002/jmv.25450. Epub 2019 Mar 18.

DOI:10.1002/jmv.25450
PMID:30840773
Abstract

BACKGROUND

Parvovirus B19 (PVB19) is transmitted via transfusion of blood and blood products. PVB19 is resistant to viral inactivation methods, which poses a threat to blood safety. We investigated the prevalence of PVB19 antibodies and DNA in healthy blood donors from the South African National Blood Bank Service to evaluate the necessity of PVB19 DNA testing.

STUDY DESIGN AND METHOD

A retrospective analysis of 1500 residual plasma specimens from healthy blood donors from the SANBS repository were screened in mini-pools of 20 for PVB19 DNA using a quantitative polymerase chain reaction (PCR). Positive pools were resolved by individual viral load testing and screened for PVB19 immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies to correlate viral loads with serological status. PVB19 IgG prevalence was determined by testing 90 randomly selected specimens from the 1500 plasma specimens.

RESULTS

The prevalence of PVB19 IgG, IgM and IgG, and DNA was 62.2%, 0.06%, and 0.9%, respectively. Fourteen of the 1500 blood donor specimens received, had detectable PVB19 viral loads. Nine of the fourteen donors with detectable viral loads were PVB19 IgG seropositive. The PVB19 viral loads ranged from 1.81 to 5.32 log IU/mL. Four of the fourteen viraemic donors had a viraemia >10 IU/mL.

CONCLUSION

We have demonstrated a low prevalence of PVB19 DNA in SANBS blood donors. The predominance of low-level viraemia and the presence of PVB19 antibodies, suggests that the risk of transfusion transmission of PVB19 among SANBS donors may be relatively low.

摘要

背景

细小病毒 B19(PVB19)通过输血和血液制品传播。PVB19 对病毒灭活方法具有抗性,这对血液安全构成威胁。我们调查了南非国家血库服务中心健康献血者中 PVB19 抗体和 DNA 的流行情况,以评估进行 PVB19 DNA 检测的必要性。

研究设计和方法

对来自 SANBS 存储库的 1500 份健康献血者剩余血浆标本进行回顾性分析,采用实时定量聚合酶链反应(PCR)以 20 份为一组对 1500 份血浆标本进行 PVB19 DNA 筛查。对阳性组进行个体病毒载量检测,并对 PVB19 免疫球蛋白 M(IgM)和免疫球蛋白 G(IgG)抗体进行筛查,以将病毒载量与血清学状态相关联。通过对 1500 份血浆标本中的 90 份随机标本进行 PVB19 IgG 检测,确定 PVB19 IgG 的流行率。

结果

PVB19 IgG、IgM 和 IgG 以及 DNA 的流行率分别为 62.2%、0.06%和 0.9%。在 1500 份献血者标本中,有 14 份标本可检测到 PVB19 病毒载量。在 14 份可检测到病毒载量的献血者中,有 9 份为 PVB19 IgG 血清阳性。PVB19 病毒载量范围为 1.81 至 5.32 log IU/mL。在 14 份病毒血症献血者中,有 4 份病毒血症>10 IU/mL。

结论

我们证明了 SANBS 献血者中 PVB19 DNA 的低流行率。低水平病毒血症的流行和 PVB19 抗体的存在表明,SANBS 献血者之间 PVB19 经输血传播的风险可能相对较低。

相似文献

1
Parvovirus B19 in South African blood donors.南非献血者中的细小病毒 B19。
J Med Virol. 2019 Jul;91(7):1217-1223. doi: 10.1002/jmv.25450. Epub 2019 Mar 18.
2
Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors.伊朗献血者中细小病毒 B19 的血清流行率、分子流行病学和 DNA 水平定量分析。
J Med Virol. 2018 Aug;90(8):1318-1322. doi: 10.1002/jmv.25195. Epub 2018 May 1.
3
The human parvovirus B19/human immunodeficiency virus co-infection in healthy eligible voluntary blood donors at the Blood Transfusion National Center in Kinshasa.金沙萨国家输血中心健康合格自愿献血者中人类细小病毒B19/人类免疫缺陷病毒合并感染情况
Pan Afr Med J. 2020 Mar 10;35:69. doi: 10.11604/pamj.2020.35.69.21018. eCollection 2020.
4
The seroprevalence of parvovirus B19 antibody in blood donors at the National Blood Transfusion Center in Kinshasa.金沙萨国家输血中心献血者中B19微小病毒抗体的血清流行率。
J Med Virol. 2020 Mar;92(3):288-294. doi: 10.1002/jmv.25613. Epub 2019 Nov 18.
5
Investigation of the prevalence of human parvovirus B19 DNA in Korean plasmapheresis donors.韩国血浆置换献血者中B19型人细小病毒DNA流行率的调查。
Korean J Lab Med. 2010 Feb;30(1):58-64. doi: 10.3343/kjlm.2010.30.1.58.
6
Parvovirus B19 seroprevalence, viral load, and genotype characterization in volunteer blood donors from southern Brazil.巴西南部献血者中细小病毒 B19 的血清流行率、病毒载量和基因型特征。
J Med Virol. 2019 Jul;91(7):1224-1231. doi: 10.1002/jmv.25453. Epub 2019 Mar 25.
7
Prevalence of human erythrovirus B19 DNA in healthy Belgian blood donors and correlation with specific antibodies against structural and non-structural viral proteins.比利时健康献血者中人类细小病毒B19 DNA的流行率及其与针对病毒结构和非结构蛋白的特异性抗体的相关性
Vox Sang. 2003 May;84(4):300-7. doi: 10.1046/j.1423-0410.2003.00299.x.
8
Persistence of Parvovirus B19 (B19V) DNA and humoral immune response in B19V-infected blood donors.B19 病毒(B19V)DNA 及体液免疫应答在 B19V 感染献血者中的持续存在。
Vox Sang. 2014 Oct;107(3):226-32. doi: 10.1111/vox.12162. Epub 2014 Jun 11.
9
Prevalence of human parvovirus B19 and TT virus in a group of young haemophiliacs in South Africa.南非一组年轻血友病患者中人类细小病毒B19和TT病毒的流行情况。
Haemophilia. 2000 Mar;6(2):93-7. doi: 10.1046/j.1365-2516.2000.00371.x.
10
Low human parvovirus B19 (B19V) DNA prevalence in blood donors from Central-West Brazil.巴西中西部地区献血者中低水平人细小病毒 B19(B19V)DNA 流行情况。
J Med Microbiol. 2019 Apr;68(4):622-626. doi: 10.1099/jmm.0.000957. Epub 2019 Mar 7.

引用本文的文献

1
Ensuring Transfusion Safety: Screening Blood Donors for Human Parvovirus B19.确保输血安全:筛查献血者是否感染人细小病毒B19
Cureus. 2024 Aug 21;16(8):e67359. doi: 10.7759/cureus.67359. eCollection 2024 Aug.
2
Parvovirus B19 and Parvovirus 4 infections among healthy blood donors; A prevalence report from Iran.健康献血者中B19细小病毒和4型细小病毒感染情况;来自伊朗的患病率报告。
IDCases. 2024 Aug 5;37:e02055. doi: 10.1016/j.idcr.2024.e02055. eCollection 2024.
3
Detection and analysis of parvovirus B19 among blood donors in a regional blood center in Eastern China.
中国东部某地区血液中心献血者中微小病毒B19的检测与分析。
Heliyon. 2024 Jul 30;10(15):e35431. doi: 10.1016/j.heliyon.2024.e35431. eCollection 2024 Aug 15.
4
Molecular and serological markers of human parvovirus B19 infection in blood donors: A systematic review and meta-analysis.献血者中人类细小病毒B19感染的分子和血清学标志物:一项系统评价和荟萃分析。
Asian J Transfus Sci. 2021 Jul-Dec;15(2):212-222. doi: 10.4103/ajts.ajts_185_20. Epub 2021 Nov 1.
5
Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine.疫情爆发后献血者中人类细小病毒B19的感染频率:流行病学情况对输血医学的相关性。
Heliyon. 2020 May 4;6(5):e03869. doi: 10.1016/j.heliyon.2020.e03869. eCollection 2020 May.
6
Emtricitabine-induced pure red cell aplasia.恩曲他滨诱发的纯红细胞再生障碍。
South Afr J HIV Med. 2019 Sep 23;20(1):983. doi: 10.4102/sajhivmed.v20i1.983. eCollection 2019.